CD30 is overexpressed in many T-cell lymphoma (TCL) entities, including subsets of peripheral T-cell lymphomas (PTCL) and cutaneous T-cell lymphomas (CTCL). This evidence concerns the gene TNFRSF8 and T-cell non-Hodgkin lymphoma.